Research map: Comparative effectiveness of dupilumab and JAK inhibitors in atopic dermatitis: Dose reduction compromises efficacy of JAK inhibitors—The CORNERSTONE study

Back to the article

Papers in this map

  1. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis · Thomas R.M. Bieber · 2021 · 473 citations · Cited by this paper
  2. 73223 Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program: A Randomized Controlled Trial · 2026 · Related
  3. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial · Kristian Reich · 2022 · 252 citations · Cited by this paper
  4. 73890 Cost-Conscious Care Strategies for Dermatology · 2026 · Related
  5. An update on the microbiology, immunology and genetics of seborrheic dermatitis · Jónas A. Aðalsteinsson · 2020 · 227 citations · Cited by this paper
  6. 72313 Impact of Microneedling Characteristics and Drug Properties on the Efficacy of Microneedling-Assisted Drug Delivery: A Systematic Review and Meta-Analysis with Biochemical, Histologic, and Ultrastructural Imaging Correlation · 2026 · Related
  7. Real‐World Efficacy of Dupilumab in Chinese Atopic Dermatitis Patients and Development of a Prediction Model · Ruojun Wang · 2026 · 2 citations · Cited by this paper
  8. 77577 Diagnostic Challenges in Pediatric Hidradenitis Suppurativa: Hidden in Plain Sight · 2026 · Related
  9. 76457 Assessment of Large Language Model-Generated Dermatology Images: Accuracy, Realism, and Educational Utility · 2026 · Related
  10. 76056 Prospective, Double-Blind, Vehicle Controlled Assessment of Topical Bakuchiol on Photoaging in a Chinese Population · 2026 · Related
  11. A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis · 2026 · Related
  12. 74363 Differences in Skin Cancer Presentation by Race: A County Hospital Retrospective Analysis · 2026 · Related
  13. 77194 Sentinel Lymph Node Biopsy Does Not Improve Prognostic Stratification in Thin Melanoma: A Competing-Risks Analysis · 2026 · Related

Source: OpenAlex (CC0)